IURISCI, IDA
 Distribuzione geografica
Continente #
EU - Europa 133
NA - Nord America 130
AS - Asia 86
SA - Sud America 8
AF - Africa 1
Totale 358
Nazione #
US - Stati Uniti d'America 130
SG - Singapore 33
UA - Ucraina 31
CN - Cina 27
IE - Irlanda 24
SE - Svezia 24
TR - Turchia 18
GB - Regno Unito 17
FR - Francia 13
BR - Brasile 8
DE - Germania 8
FI - Finlandia 6
IN - India 5
IT - Italia 4
RU - Federazione Russa 4
ES - Italia 2
IL - Israele 1
IR - Iran 1
KG - Kirghizistan 1
ZA - Sudafrica 1
Totale 358
Città #
Jacksonville 30
Chandler 27
Singapore 25
Dublin 24
Southend 14
Princeton 11
Izmir 10
Nanjing 9
Dearborn 6
Beijing 5
Cambridge 5
Boardman 4
Santa Clara 4
Altamura 3
Hangzhou 3
Nanchang 3
Changsha 2
Frankfurt am Main 2
New York 2
Wilmington 2
Alvorada 1
Ann Arbor 1
Ardabil 1
Augusta 1
Betim 1
Bishkek 1
Bom Jesus do Tocantins 1
Conegliano 1
Cordeirópolis 1
Foz do Iguaçu 1
Grevenbroich 1
Helsinki 1
Jiaxing 1
Johannesburg 1
Kunming 1
Lagoa Santa 1
Lanzhou 1
Limeira 1
Madrid 1
Maricá 1
Phoenix 1
San Mateo 1
Secaucus 1
Shenyang 1
Simi Valley 1
Totale 216
Nome #
Relief of symptoms after gefitinib is associated with improvement of rest/activity rhythm in advanced lung cancer 85
Concentrations of Galectin-3 in the Sera of Normal Controls and Cancer Patients 79
Synthetic lactulose amines: novel class of anticancer agents that induce tumor-cell apoptosis and inhibit galectin-mediated homotypic cell aggregation and endothelial cell morphogenesis. 75
Immunohistochemical and serological 90K/Mac-2BP detection in hepatocellular carcinoma patients: different behaviour of two monoclonal antibodies 68
Improved tumor control through circadian clock induction by Seliciclib, a cyclin-dependent kinase inhibitor. 57
Totale 364
Categoria #
all - tutte 1.551
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.551


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202132 5 0 5 0 5 5 1 0 3 5 3 0
2021/202220 0 0 0 7 2 0 0 1 1 0 3 6
2022/202378 5 7 9 9 8 16 4 6 8 2 2 2
2023/202428 2 2 4 0 0 9 8 0 0 1 0 2
2024/202568 5 25 13 2 0 2 3 3 6 1 7 1
Totale 364